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Summary: The purpose of the study was to try to detect at an early stage the important cardiovascular risk
factors associated with increased concentrations of blood lipids, notably cholesterol. The trial was based on
the screening of 102 families, including 219 children, 8 — 18 years of age and their parents. A group of young
adults, 19—25 years of age, was included in the study. All subjects were derived from a paediatric practice.
In addition to total cholesterol, VLDL-, LDL-, HDL-cholesterol and apolipoproteins A-I and B were also
measured. The study identified a significant number of school-children and adolescents with hyperlipidaemia,
predominantly hypercholesterolaemias type II-A. There was a close relationship between their blood lipids
and those of their parents. The study demonstrates the importance of including parents in studies of this
kind. Total cholesterol proved to be a reliable parameter for screening. The value of apolipoproteins in such
screening is discussed.
Introduction
It is generally agreed that an increased concentration
of blood lipids, notably cholesterol, is one of the most
important risk factors in cardiovascular disease. Al-
though it is well known that anomalies in lipid me-
tabolism may be found in children, lipid determina-
tions are not normally included in paediatric screening
programmes for the early detection of risk factors.
However, in view of the potential prevention of car-
diovascular disease this age group could be important.
This topic has already led to a series of studies of
different age ranges and has yielded various results.
General agreement about the screening of children
however does not exist (1 — 5). It was the purpose of
the present study to gather in a paediatric practice
more information about the value of such screening.
The laboratory work of this study was supported in part by
a grant from the Swiss National Science Foundation.
Subjects and Methods
Subjects
The study was based upon the screening of blood lipids in
families, i.e. parents and their children between the age of 8
and 18 years. The collective included 102 parent couples and
their 116 sons and 103 daughters. In a second phase of the
study, a group of young adults, 19 to 25 years old, from the
same families, was also included. All families were recruited at
random from a normal paediatric practice, belonging predom-
inantly to middle class residents of the city of Berne.
After 3—4 years, it was possible to re-examine the majority of
the study group, children and parents. In addition, children
were monitored repeatedly up to 8 years, until the end of
puberty. Individuals were not tested during periods of illness.
Methods
Total cholesterol, VLDL-, LDL-, HDL-cholesterol were meas-
ured by enzymatic methods in sera collected after 12 h fasting.
VLDL were prepared with the aid of an Air Fuge (Beckman).
LDL were precipitated with phosphotungstate and Mg2+ (6).
Apolipoprotein B was measured by a non-competitive ELISA,
using LDL as a primary, and OMEGA lipid fraction control
serum (Travenol) as a secondary standard (7). Apolipoprotein
A-I was determined by electro-immuno-assay with sheep anti-
bodies (8), using isolated apolipoprotein A-I as a primary, and
OMEGA lipid fraction control serum as secondary standard.
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Results
Figure 1 shows the level of total cholesterol and its
lipoprotein fractions in all participants in the study
during their development. An important peak for
total cholesterol and LDL-cholesterol is noted at
8 — 12 years of age in boys and to a lesser extent in
girls. This is followed by a gradual decrease during
puberty, reaching a minimum at 18 — 19 years of age
for boys and at 16 —17 years for girls. After puberty,
there is a distinct rise in the mean concentration of
total cholesterol and LDL-cholesterol, especially in
males. The level of HDL-cholesterol is remarkably
constant, although the mean levels for males decrease
slightly during puberty towards a permanently lower
level, while HDL values for females increase slowly
after puberty towards a stable higher level. VLDL-
cholesterol remains at about the same level during the
development of both sexes during childhood and ad-
olescence, but clear differences appear after 20 — 25
years of age, values for males showing a marked
upward trend, and those for females showing a similar
but less pronounced increase.
Triacylglycerol is not included in the study, since the
interpretation of this parameter as a risk factor for
coronary heart disease is not clear. Figure 2 shows
the distribution of apolipoprotein A-I and B concen-
trations in the study group. For the two sexes, the
mean values for apolipoprotein A-I are very similar
until puberty, after which the values show a distinct
rise in females, whereas the values rise slightly in
males, then decrease. Similarly, the mean values for
apolipoprotein B stay close together for both sexes at
a more-or-less steady level, separating only at 20 — 25
years of age, when the values for males show a steep
rise, those for females staying much lower.
Figure 3 shows mean values of the atherogenic indices,
HDL-cholesterol/LDL-cholesterol and apolipopro-
tein A-I/apolipoprotein B. The values for both sexes
lie close together until puberty, but separate there-
after, showing a downward trend which is more pro-
nounced for males, especially in the case of the HDL-
cholesterol/LDL-cholesterol ratio.
Figure 4 and table 1 demonstrate the close hereditary
relationship between children and their parents with
respect to cholesterol values. High and low parental
values correspond to high and low mean levels, re-
spectively, in both their sons and daughters.
Our lipid screening provided the following data for
total cholesterol for boys and girls and their parents.
A fraction of 0.41 of boys presented levels below 4.7
mmol/1 (< 180 mg/dl); 0.11 had a moderate risk level
of > 5.7-6.7 mmol/1 (> 220-260 mg/dl); 0.06 pos-
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Fig. 1. Development of total cholesterol and its lipoprotein
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sessed a high risk level of > 6.7 mmol/1 (>260 mg/dl),
of which 0.025 showed a very high risk level of > 7.7
mmol/1 (> 300 mg/dl) (2 cases of primary familial
hyperlipidaemia type II-A and 1 case of a secondary
type (nephrosis)), while 0.13 of the fathers also pre-
sented the same levels.
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Tab. 1. Correlation between cholesterol values (x ± SD) of children and parents.
Relationship
Fathers/sons
Fathers/daughters
Mothers/sons
Mothers/daughters
Ν
81/116
70/103
81/116
70/103
fathers
sons
fathers
daughters
mothers
sons
mothers
daughters
Cholesterol
(mmol/l)
6.3 ± 1.24
4.7 ± 0.90
6.2 + 1.13
4.7 ± 0.72
5.6 ± 1.08
4.7 ± 0.85
5.6 + 1.13
4.7 ± 0.74
(mg/dl)
244 + 48
183 ± 35
241 + 44
183 ± 27
218 + 42
182 ± 34
219 + 44
184 ± 29
r
0.33
0.42
0.33
0.54
A fraction of 0.53 of girls presented levels below 4.7
mmol/l (< 180 mg/dl); 0.07 had moderate risk levels
of > 5.7-6.7 mmol/l (> 220-260 mg/dl), while
none was in the high risk group > 6.7 mmol/l (> 260
mg/dl); 0.12 of their mothers were however in this
latter group.
In both sexes secondary alimentary hyperlipidaemias
of varying degree, with or without certain undefined
hereditary factors, were frequently found. After 3-4
years, it was possible to re-check approximately 0.7
of the original family study group, parents and chil-
dren. In addition, most children, especially those with
cholesterol concentrations higher than 4.7 mmol/l
(> 180 mg/dl), were re-checked at 1 - 3 year intervals,
up to 7 —8 years, until the end of puberty. A fraction
of 0.12—0.13 of the children who originally had more
than 4.7 mmol/l (> 180 mg/dl) later possessed lower
cholesterol values. A fraction of 0.04—0.05 of those
who originally had less than 4.7 mmol/l (< 180 mg/dl)
later developed higher levels. The majority, however,
remained within the original range, above or below
4.7 mmol/l (180 mg/dl), although during puberty there
was a general downward trend. Individuals who had
displayed moderately elevated cholesterol levels at
puberty were re-examined in their early twenties; one
additional case (0.01) was found among the sons with
a very high risk level (> 7.7 mmol/l; > 300 mg/dl),
and two more cases among the girls, both with high
risk levels (> 6.7 mmol/l; > 260 mg/dl). Each of these
was an example of familial hyperlipidaemia type II-A.
Among the children there were two cases (0.01), one
of each sex, which were compatible with a heterozy-
gous type of familial hyperlipoproteinaemia.
During the 3—4-year examination period, the parents
displayed little change in cholesterol levels, although
there was a slight decrease (around 10—15%) in those
with elevated levels who had been on a diet. In con-
trast, there was a slight increase in those who had not
dieted and also in those females in menopause.
On the whole, the individual values of apolipoproteins
A-I and B in our study confirm the results of our
lipoprotein screening.
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Discussion
Although our study is based upon a relatively small
number of subjects, it nevertheless allowed us to detect
a series of elevated cholesterol levels in children and
their parents. The total- and LDL-cholesterol levels
(fig. 1) of the pre-pubertal peak in boys and girls,
between 8 and 12 years of age, were very pronounced.
After the well known decrease during and after pu-
berty, we noted again relatively high mean total and
LDL-cholesterol values in adults, especially in fathers.
It was of interest to note that the total and LDL-
cholesterol values showed similar trends to those
found in other, large-scale, studies (9). The relatively
high mean cholesterol values which we found in both
sexes correspond to general findings in the Swiss
population (10, 11). It must also be noted that most
of the families in this study were in no way alerted to
the relationship between blood cholesterol levels and
diet, a fact which holds true for the majority of our
general population.
The graphs showing apolipoprotein A-I and B values
(fig. 2) mirror the HDL- and LDL-cholesterol data
and clearly demonstrate the difference between the
sexes after puberty. The same holds true for the ath-
erogenic indices, HDL-cholesterol/LDL-cholesterol
and apolipoprotein A-I/apolipoprotein B (fig. 3).
It is well known, that in addition to alimentary fac-
tors, hereditary also play a major role (12). This
relationship is clearly evident in our subjects (fig. 4;
tab. 1).
Apolipoproteins A-I and B were included in our study
because these parameters have proven to be equally
or even more reliable than lipoproteins for the detec-
tion of coronary heart disease risks (13 — 15). This
holds especially true for apolipoprotein B for some
special cases of familial coronary heart disease
(16-18).
The benefit attached to lipid screening in paediatrics
is still controversial, but we do not believe that it is
best to wait until a parent has suffered coronary
disease before examining the children. It must also be
noted that the parental histories in almost all our
subjects had been silent. Our findings support the
view that screening for lipids should in fact be started
in all children (19). The question concerning the best
age to start however remains open and cannot be
answered by our relatively small study. For practical
reasons we started our trial at a lower age limit of
7 — 8 years, which corresponded to the school entry
period, and proved to be favourable for family co-
operation. The 7 —8-year bracket precedes the pre-
pubertal peak of total and LDL-cholesterol values,
and is perhaps the most suitable for routine screening
(20). Cholesterol screening in the very young child
has given unsatisfactory results, except in families
with known familial hypercholesterolaemia (21, 22).
As an upper limit for acceptable cholesterol values
for children and adolescents we chose those proposed
by the Consensus Conference (23), i. e. approximately
4.7mmol/l(180mg/dl).
Later re-examination, during puberty and thereafter
proved to be in various cases an indispensable aid for
diagnosis and prognosis, particularly in relation to
elevated cholesterol values. Thus, re-checking allowed
us to identify a number of false "positive" and false
"negative" values. Individuals whose values remained
elevated during puberty, the period normally associ-
ated with minimum levels, were followed into their
twenties, thus permitting an evaluation of their risk
status. Late re-examination proved especially helpful
in females, who tend to lay behind males in developing
high risk levels.
With regard to the results of our search for the early
detection of cardiovascular risks, the fraction of cases
with severe hyperlipoproteinaemia was small (0.02 —
0.03), although it reached 0.06 when re-checks in the
early twenties were included. However, any single
finding is important, because it contributes to the
assessment of measures that might be taken to reduce
the risks in young people before too much damage
has occurred. Furthermore, the early detection of
those many cases of hyperlipidaemia, which are due
mainly to unfavourable alimentary factors, seems to
be essential. Such cases must be considered to be at
potentially high risk, and they might also be antici-
pated from the parental screening.
Therapeutic measures for our children with elevated
cholesterol levels were limited to the recommendation
of a diet low in cholesterol and saturated fat. Medi-
cation was restricted to cholestyramine and was ap-
plied only to a few adolescents who had very high
levels of cholesterol.
We advocate the inclusion of parents in paediatric
lipid screening, since we have seen that it is helpful in
establishing a diagnosis in children. It is, of course,
also valuable for detecting risk factors in the parents
themselves, and it assists the introduction of dietary
control measures within the family. This kind of com-
bined screening could be an important contribution
to the field of preventive medicine, and it could ap-
propriately be undertaken primarily by the paediatri-
cian, who has easy access to young adults through
his contact with their young children.
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Our study showed that total cholesterol is a reliable
parameter for the detection of cardiovascular risks in
children, if duly re-checked during puberty. Addi-
tional parameters, such as lipoprotein fractions and
apolipoproteins, notably in normolipidaemic individ-
uals with familial coronary heart disease risks, are
useful in establishing a detailed diagnosis and in clas-
sifying particular cases.
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